Mosapride is a gastroprokinetic agent used to treat gastrointestinal disorders such as dyspepsia, gastroesophageal reflux disease, and irritable bowel syndrome. Impurities in Mosapride can affect its safety and efficacy, so it is important to ensure the purity of the medication. Mosapride impurities can include related compounds, degradation products, and residual solvents, which must be identified and quantified during drug development and manufacturing to ensure product quality and safety.
